Outset Medical (OM) Income towards Parent Company (2019 - 2026)

Outset Medical (OM) has reported Income towards Parent Company for 8 consecutive years, with -$19.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Income towards Parent Company rose 26.39% year-over-year to -$19.0 million; the TTM figure through Mar 2026 stood at -$74.8 million (up 34.24% YoY), while the FY2025 annual figure was -$81.7 million, up 36.2% from the prior year.
• Income towards Parent Company advanced to -$19.0 million in Q1 2026 per OM's latest filing, from -$19.5 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at -$17.8 million in Q3 2025 and bottomed at -$46.2 million in Q3 2023.
• Historically, Income towards Parent Company has averaged -$33.2 million across 5 years, with a median of -$36.9 million in 2022.
• Annual changes were most pronounced in 2022 — Income towards Parent Company tumbled 45.12% — and 2025, when it jumped 46.19%.
• Outset Medical's Income towards Parent Company stood at -$41.4 million in 2022, then increased by 6.86% to -$38.6 million in 2023, then surged by 33.58% to -$25.6 million in 2024, then advanced by 23.98% to -$19.5 million in 2025, then increased by 2.63% to -$19.0 million in 2026.
• Business Quant data shows OM's Income towards Parent Company at -$19.0 million in Q1 2026, -$19.5 million in Q4 2025, and -$17.8 million in Q3 2025.